These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 2565146)

  • 1. Repeated reserpine administration up-regulates the transduction mechanisms of D1 receptors without changing the density of [3H]SCH 23390 binding.
    Missale C; Nisoli E; Liberini P; Rizzonelli P; Memo M; Buonamici M; Rossi A; Spano P
    Brain Res; 1989 Mar; 483(1):117-22. PubMed ID: 2565146
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acute reserpine treatment induces down regulation of D-1 dopamine receptor associated adenylyl cyclase activity in rat striatum.
    Thomas KL; Rose S; Jenner P; Marsden CD
    Biochem Pharmacol; 1992 Jul; 44(1):83-91. PubMed ID: 1321631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Developmental and age-related changes in D1-dopamine receptors and dopamine content in the rat striatum.
    Giorgi O; De Montis G; Porceddu ML; Mele S; Calderini G; Toffano G; Biggio G
    Brain Res; 1987 Oct; 432(2):283-90. PubMed ID: 2960426
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dopamine supersensitivity and D1/D2 synergism are unrelated to changes in striatal receptor density.
    LaHoste GJ; Marshall JF
    Synapse; 1992 Sep; 12(1):14-26. PubMed ID: 1357762
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adaptive mechanisms of striatal D1 and D2 dopamine receptors in response to a prolonged reserpine treatment in mice.
    Rubinstein M; Muschietti JP; Gershanik O; Flawia MM; Stefano FJ
    J Pharmacol Exp Ther; 1990 Feb; 252(2):810-6. PubMed ID: 2138223
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vivo partial inactivation of dopamine D1 receptors induces hypersensitivity of cortical dopamine-sensitive adenylate cyclase: permissive role of alpha 1-adrenergic receptors.
    Trovero F; Hervé D; Blanc G; Glowinski J; Tassin JP
    J Neurochem; 1992 Jul; 59(1):331-7. PubMed ID: 1351927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A comparison between dopamine-stimulated adenylate cyclase and 3H-SCH 23390 binding in rat striatum.
    Andersen PH; Grønvald FC; Jansen JA
    Life Sci; 1985 Nov; 37(21):1971-83. PubMed ID: 2415793
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Postnatal development of striatal dopamine function. II. Effects of neonatal 6-hydroxydopamine treatments on D1 and D2 receptors, adenylate cyclase activity and presynaptic dopamine function.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):273-7. PubMed ID: 2110042
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D1 dopamine receptors in the rat retina: effect of dark adaptation and chronic blockade by SCH 23390.
    Porceddu ML; De Montis G; Mele S; Ongini E; Biggio G
    Brain Res; 1987 Oct; 424(2):264-71. PubMed ID: 2960425
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Loss of D1/D2 dopamine receptor synergisms following repeated administration of D1 or D2 receptor selective antagonists: electrophysiological and behavioral studies.
    Hu XT; White FJ
    Synapse; 1994 May; 17(1):43-61. PubMed ID: 7913772
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of chronic SCH23390 treatment on the biochemical and behavioral properties of D1 and D2 dopamine receptors: potentiated behavioral responses to a D2 dopamine agonist after selective D1 dopamine receptor upregulation.
    Hess EJ; Albers LJ; Le H; Creese I
    J Pharmacol Exp Ther; 1986 Sep; 238(3):846-54. PubMed ID: 3018223
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
    Hu XT; White FJ
    Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-hydroxydopamine treatments enhance behavioral responses to intracerebral microinjection of D1- and D2-dopamine agonists into nucleus accumbens and striatum without changing dopamine antagonist binding.
    Breese GR; Duncan GE; Napier TC; Bondy SC; Iorio LC; Mueller RA
    J Pharmacol Exp Ther; 1987 Jan; 240(1):167-76. PubMed ID: 3100767
    [TBL] [Abstract][Full Text] [Related]  

  • 14. D1 receptor stimulation inhibits dopamine cell activity after reserpine treatment but not after chronic SCH 23390: an effect blocked by N-methyl-D-aspartate antagonists.
    Huang KX; Walters JR
    J Pharmacol Exp Ther; 1992 Jan; 260(1):409-16. PubMed ID: 1530977
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cocaine-induced behavioral sensitization and D1 dopamine receptor function in rat nucleus accumbens and striatum.
    Mayfield RD; Larson G; Zahniser NR
    Brain Res; 1992 Feb; 573(2):331-5. PubMed ID: 1387030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Altered dopamine receptor mediated signal transmission in the striatum of aged rats.
    May T; Sugawa M
    Brain Res; 1993 Feb; 604(1-2):106-11. PubMed ID: 8457839
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postnatal development of striatal dopamine function. I. An examination of D1 and D2 receptors, adenylate cyclase regulation and presynaptic dopamine markers.
    Broaddus WC; Bennett JP
    Brain Res Dev Brain Res; 1990 Mar; 52(1-2):265-71. PubMed ID: 2331795
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evidence for different states of the dopamine D1 receptor: clozapine and fluperlapine may preferentially label an adenylate cyclase-coupled state of the D1 receptor.
    Andersen PH; Braestrup C
    J Neurochem; 1986 Dec; 47(6):1822-31. PubMed ID: 2945903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of a D1 dopamine receptor, not linked to adenylate cyclase, on lactotroph cells.
    Schoors DF; Vauquelin GP; De Vos H; Smets G; Velkeniers B; Vanhaelst L; Dupont AG
    Br J Pharmacol; 1991 Aug; 103(4):1928-34. PubMed ID: 1833020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Possible role of dopamine D1 receptor in the behavioural supersensitivity to dopamine agonists induced by chronic treatment with antidepressants.
    Serra G; Collu M; D'Aquila PS; De Montis GM; Gessa GL
    Brain Res; 1990 Sep; 527(2):234-43. PubMed ID: 1979237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.